SCHEMBL4435289

SCHEMBL4435289

CC(C)Oc1ccc(C(=O)Nc2ccccc2NC(=O)c2ccccc2)cc1Cl

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.67
HDAC8 Q9BY41 3/20 0.67
HDAC6 Q9UBN7 3/20 0.67
KMT2A Q03164 4/20 0.59
NPC1 O15118 4/20 0.59
RAB9A P51151 4/20 0.59
ALDH1A1 P00352 3/20 0.59
MEN1 O00255 3/20 0.59
HTT P42858 2/20 0.59
KCNH2 Q12809 1/20 0.59
LMNA P02545 1/20 0.58
CENPE Q02224 1/20 0.55
BRPF1 P55201 1/20 0.55
NPSR1 Q6W5P4 3/20 0.55
MAPT P10636 3/20 0.55
KDM4E B2RXH2 1/20 0.55
PDE4D Q08499 1/20 0.54
RORC P51449 1/20 0.51
TOP1 P11387 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2104049 0.78 RORC (0.55) HDAC1HDAC8HDAC6KMT2ANPC1
SCHEMBL403840 0.77 RORC (0.56) KMT2ANPC1RAB9AALDH1A1MEN1
SCHEMBL2104568 0.77 CENPE (0.53) HDAC1HDAC8HDAC6KMT2ANPC1
SCHEMBL2617141 0.77 CENPE (0.86) HDAC1HDAC8HDAC6KMT2ANPC1
SCHEMBL2104572 0.77 CENPE (0.62) HDAC1HDAC8HDAC6KMT2ANPC1
SCHEMBL2103796 0.77 CENPE (0.62) HDAC1HDAC8HDAC6KMT2ANPC1
SCHEMBL14531252 0.77 RORC (0.54) HDAC1HDAC8HDAC6KMT2ANPC1
SCHEMBL4720085 0.76 CENPE (0.54) HDAC1HDAC8HDAC6KMT2ANPC1
SCHEMBL2105954 0.76 CENPE (0.61) HDAC1HDAC8HDAC6KMT2ANPC1
SCHEMBL20786870 0.76 HDAC1 (0.62) HDAC1HDAC8HDAC6KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618981-B2 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide CYTOKINETICS, INC. (US) 2009-11-17 US disclosed